FastRing FR1000
Automatic Aggregometer
- FastRing FR1000 can be applied for Quickly detecting the function of residual platelet aggregation and predict the risk of thrombosis and monitoring the efficacy of antiplatelet drugs and guide the use of drugs.
- Quickly detect the function of residual platelet aggregation and predict the risk of thrombosis.
- Whole blood microfluidic technology, giving results in 3-5 minutes
- Monitor the efficacy of antiplatelet drugs and guide the use of drugs.
- Assist doctors to develop individualized antiplatelet therapy.
- Double quality control of instrument and reagent, with strong stability
- Reagent cards are individually sealed and packaged to reduce contact infection
Easy to operate
Easy to interpret
P2Y12 Receptor
- P2Y12 receptor platelet agglutination test reagent card (turbidimetric method)
- To detect the platelet aggregation function related to the P2Y12 receptor pathway in human whole blood.
- Clinical application: Test patients who take P2Y12 receptor anti-platelet drugs,which can evaluate the efficacy of clopidogrel, ticagrelor and other drugs, and guide individualized anti-platelet therapy.
- CE certificate
P2Y12 Receptor Test Result
- Thrombin pathway is the baseline value, ADP pathway is the test value, and the percentage of inhibition is calculated.
- Detect the platelet aggregation function of the patient who takes thiophene pyridine drugs, and add PGE1 to inhibit the ADP from binding P2Y1 receptor, with better detection specificity.
Cyclooxygenase-1
- Cyclooxygenase-1 platelet agglutination test reagent card (turbidimetric method)
- To detect the platelet aggregation function related to cyclooxygenase-1 activity in human whole blood.
- Clinical application: Test patients who take cyclooxygenase-1 pathway anti-platelet drugs, which can evaluate the efficacy of aspirin drugs and guide individualized anti-platelet therapy.
- CE certificate
Cyclooxygenase-1 Test Result
- The aggregation induced by arachidonic acid can be measured ranging from 350 to 700 ARU.
- Recommended cut-off value: 550 ARU (>550 ARU: insufficient efficacy of aspirin)
- YES is recommended, and NO is not recommended
- LTA: light transmittance aggregometry
- VASP: vasodilatation stimulating phosphoprotein
- POCT: point-of-care testing.